This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Genentech, Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Rachana Ohri: Innovator in Antibody Engineering
Introduction
Rachana Ohri is a prominent inventor based in South San Francisco, CA. She has made significant contributions to the field of biotechnology, particularly in the development of engineered antibodies. Her innovative work has the potential to advance therapeutic applications in various medical fields.
Latest Patents
Rachana Ohri holds a patent for "Cysteine engineered antibodies and conjugates." This patent describes a method for preparing cysteine engineered antibodies that include a free cysteine amino acid in either the heavy or light chain. The process involves mutagenizing a nucleic acid sequence of a parent antibody, replacing specific amino acid residues with cysteine, expressing the engineered antibody, and isolating the final product. This innovative approach enhances the functionality of antibodies for therapeutic use.
Career Highlights
Rachana is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on developing innovative medicines. Her work at Genentech has allowed her to collaborate with some of the brightest minds in the industry, furthering her research and development efforts.
Collaborations
Some of Rachana's notable coworkers include Sunil Bhakta and Hans Erickson. Their collaborative efforts contribute to the advancement of antibody engineering and the development of new therapeutic solutions.
Conclusion
Rachana Ohri's contributions to the field of antibody engineering exemplify her dedication to innovation and research. Her patent on cysteine engineered antibodies showcases her ability to push the boundaries of biotechnology. Through her work at Genentech, she continues to make a significant impact in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
